The American College of Radiology® (ACR®) town hall regarding 2023 Amended Mammography Quality Standards Act (MQSA) Final Regulations is now available online.
The townhall featured a panel of experts from the U.S. Food and Drug Administration (FDA) Division of Mammography Quality Standards (DMQS) that discussed the new MQSA requirements that take effect Sept. 10. Congress enacted the MQSA in 1994 to ensure that all people have access to quality mammography for the detection of breast cancer.
For more information, contact Pamela Platt, ACR Manager/FDA Liaison, Mammography Accreditation Program.
HRSA Breast Cancer Screening for Average Risk Guideline
The U.S. Department of Health and Human Services Health Resources and Services Administration finalized its proposal for the Breast Cancer Screening for Women at Average Risk guideline.
Read moreACR Comments on Draft HRSA Breast Cancer Screening Recommendations
The American College of Radiology® (ACR®) submitted comments this week on draft recommendations for the Health Resources and Services Administration (HRSA)-supported Women's Preventive Services Guidelines , including for breast cancer screening.
Read moreNavigating Breast Imaging Guidelines
In April 2024, the U.S. Preventive Services Task Force changed the recommendations for imaging of non–BRCA-related breast cancer. The recommendations now state that biennial screening mammography is recommended for women ages 40 to 74, a pattern formerly suggested for women at least 50 years old.
Read more